Summary
Matt Blackburn challenges the mainstream narrative around melatonin supplementation, arguing that melatonin is far more than a sleep hormone. He makes the case for high-dose melatonin supplementation, citing its anti-tumor, anti-viral, anti-anxiety, and anti-inflammatory properties. Blackburn pushes back against claims that exogenous melatonin suppresses endogenous production, noting that research does not support this concern at standard or even elevated doses. He also addresses the claim by a popular neurosurgeon that melatonin changes eyeball shape, dismissing it as unsupported by clinical evidence.
Key Points
- Melatonin is not just a sleep hormone; it has anti-tumor, anti-viral, anti-anxiety, and anti-inflammatory properties
- Exogenous melatonin supplementation does not appear to suppress the body's own production
- High-dose melatonin (10-100mg+) has been studied for cancer support and neuroprotection
- Melatonin is one of the body's most powerful endogenous antioxidants, produced in every cell's mitochondria
- Claims about melatonin changing eyeball shape are not supported by any clinical study
- Melatonin production declines significantly with age, making supplementation more relevant for older adults
- Timing and dose should be individualized; start low and increase gradually
